Adithya K. Yadalam

Internal Medicine

49 Jesse Hill Jr Dr SE
Atlanta, GA 30303

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Life's Essential 8: Essential for Brain and Cognitive Health.

Life's Essential 8: Essential for Brain and Cognitive Health.

Journal: Journal of the American Heart Association

Published: July 25, 2026

The Cardiometabolic-to-Cancer Axis: Molecular Insights From Cardio-Kidney-Metabolic Syndrome Staging.

The Cardiometabolic-to-Cancer Axis: Molecular Insights From Cardio-Kidney-Metabolic Syndrome Staging.

Journal: JACC. CardioOncology

Published: June 14, 2026

Statin Use Attenuates Leuprolide-Associated Coronary Atherosclerosis Progression: A Secondary Analysis of the REVELUTION Trial.

Statin Use Attenuates Leuprolide-Associated Coronary Atherosclerosis Progression: A Secondary Analysis of the REVELUTION Trial.

Journal: JACC. CardioOncology

Published: May 29, 2026

Coronary Plaque Progression After Androgen Deprivation Therapy in Men With Prostate Cancer: A Randomized Clinical Trial.

Coronary Plaque Progression After Androgen Deprivation Therapy in Men With Prostate Cancer: A Randomized Clinical Trial.

Journal: JAMA cardiology

Published: February 18, 2026

The Comparative Prognostic Value of High Sensitivity Troponin Level and Stress Testing in Patients With Stable Coronary Artery Disease.

The Comparative Prognostic Value of High Sensitivity Troponin Level and Stress Testing in Patients With Stable Coronary Artery Disease.

Journal: Journal of the American College of Cardiology

Published: November 15, 2025

Dyslipidemia and therapies after heart transplantation: Current evidence and future directions.

Dyslipidemia and therapies after heart transplantation: Current evidence and future directions.

Journal: Journal of clinical lipidology

Published: October 03, 2025

Large-Scale Proteomics-Based Risk Score for the Prediction of Incident Cardio-Kidney-Metabolic Disease Risk.

Large-Scale Proteomics-Based Risk Score for the Prediction of Incident Cardio-Kidney-Metabolic Disease Risk.

Journal: Circulation. Genomic and precision medicine

Published: September 11, 2025

Safety and Tolerability of Short-Term Oral Triiodothyronine in Euthyroid Patients with Ischemic Heart Failure: A Phase I, Open-Label, Controlled Clinical Trial.

Safety and Tolerability of Short-Term Oral Triiodothyronine in Euthyroid Patients with Ischemic Heart Failure: A Phase I, Open-Label, Controlled Clinical Trial.

Journal: The American journal of cardiology

Published: August 29, 2025

Safety and Tolerability of Short-Term Oral Triiodothyronine in Euthyroid Patients with Ischemic Heart Failure: A Phase I, Open-Label, Controlled Clinical Trial.

Safety and Tolerability of Short-Term Oral Triiodothyronine in Euthyroid Patients with Ischemic Heart Failure: A Phase I, Open-Label, Controlled Clinical Trial.

Journal: The American journal of cardiology

Published: August 29, 2025

Response to Letter to the Editor by He et al.

Response to Letter to the Editor by He et al.

Journal: Journal of cardiac failure

Published: May 08, 2025

Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels and Long-Term Cardiovascular Outcomes in Survivors of Breast Cancer: A UK Biobank Study.

Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels and Long-Term Cardiovascular Outcomes in Survivors of Breast Cancer: A UK Biobank Study.

Journal: Journal of the American Heart Association

Published: May 02, 2025

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Mediates the Impact of Diabetes on Adverse Outcomes in Coronary Artery Disease.

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Mediates the Impact of Diabetes on Adverse Outcomes in Coronary Artery Disease.

Journal: Diabetes care

Published: April 22, 2025

Showing 1-12 of 28

Last Updated: 09/26/2026